Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind Randomized Controlled Trial to Assess the Lot-to-lot Consistency of Sci-B-Vac™ in Adults (CONSTANT)

NCT03408730 is registered in ClinicalTrials.gov with VBI Vaccines Inc. as lead sponsor.

NCT NCT03408730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03408730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind Randomized Controlled Trial to Assess the Lot-to-lot Consistency of Sci-B-Vac™ in Adults (CONSTANT)
Lead sponsor
VBI Vaccines Inc.
Phase
Phase 3
Overall status
Completed
Start date
December 14, 2017
Completion date
October 1, 2019
Enrollment
2,838 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b vaccines